Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Type Psoriasis”

168 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 168 results

Not applicableStudy completedNCT00800982
What this trial is testing

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Early research (Phase 1)Study completedNCT01646567
What this trial is testing

SHP-141C in Plaque Type Psoriasis

Who this might be right for
Plaque Type Psoriasis
TetraLogic Pharmaceuticals 14
Testing effectiveness (Phase 2)Study completedNCT02209753
What this trial is testing

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 182
Testing effectiveness (Phase 2)Study completedNCT03131570
What this trial is testing

Safety and Efficacy of Secukinumab in Mild Psoriasis

Who this might be right for
Psoriasis
James G. Krueger, MD, PhD 23
Testing effectiveness (Phase 2)Study completedNCT00230529
What this trial is testing

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 249
Large-scale testing (Phase 3)Study completedNCT03047395
What this trial is testing

Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Who this might be right for
Psoriasis
AbbVie 2,170
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Testing effectiveness (Phase 2)Study completedNCT00823693
What this trial is testing

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

Who this might be right for
Psoriasis
Revotar Biopharmaceuticals AG 107
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06723171
What this trial is testing

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsorisisPlaque Psoriasis
Io Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254
Large-scale testing (Phase 3)Study completedNCT00267969
What this trial is testing

Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 766
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Testing effectiveness (Phase 2)Study completedNCT00604682
What this trial is testing

Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
Amgen 19
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Load More Results